Latest News
Asahi Kasei Corporation
- Asahi Kasei Corporation Estimates – TSE:3407
- Asahi Kasei Secures Top-Tier Carbon Verification for Acrylonitrile
- Asahi Kasei secures third-party verification for green acrylonitrile
- Asahi Kasei Corporation - Announces Cancellation Of Treasury Shares
- FDA approves Asahi Kasei's Hovilpri for treatment-refractory HSV infections
- FDA approves Asahi Kasei’s Hovilpri for refractory HSV
- Aicuris acquisition delivers new drug for Asahi Kasei
- Asahi Kasei buyout yields novel FDA herpes nod in immunocompromised patients
- Asahi Kasei's recently acquired helicase primase inhibitor gets FDA approval for herpes lesions
- US FDA approves Asahi Kasei's drug for persistent herpes infections
- Asahi Kasei wraps years of global dealmaking into a single brand
- Asahi Kasei to Integrate Global Pharmaceutical Brand Under Asahi Kasei Therapeutics
Headlines from the last 30 days, linking to the original publishers. See all market news →